Company Profile
Enlivex Therapeutics Stock Price, News & Analysis
- Ticker:
- ENLV
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Israel and listed in the U
Stock performance
1.98 USD (-9.17%)
Close
Last updated: August 6, 2026
205M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, ENLV closed down 9.17% at $1.98. No new same-company headline was identified in the current news window.
Company overview
Business overview
Enlivex Therapeutics is an immunotherapy company focused on macrophage reprogramming and inflammation-related disease. Its story is centered on harnessing innate immunity to address hard-to-treat conditions.
Geographic Base and Sector Classification
Enlivex is headquartered in Israel and listed in the U.S. market. It sits in small-cap immunology biotechnology.
Business Model Characteristics
The company depends on translational validation, early clinical progress, and capital support. Investors typically watch proof-of-concept data and whether the platform can create durable value.
Position Within the Biotechnology Landscape
Enlivex occupies a niche innate-immunity position within biotech. The stock is driven by whether macrophage reprogramming can become a meaningful therapeutic strategy.
Future catalysts
Enlivex’s catalysts are Allocetra and its osteoarthritis / immunology programs, along with any update that clarifies whether the platform still has a viable path. The company remains data-sensitive.
Recent news
- 01
- 02
- 03
Enlivex Announces $400,000,000 Private Placement
Source: Enlivex Therapeutics
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Enlivex Therapeutics (ENLV)?
Enlivex Therapeutics (ENLV) most recently closed at 1.98 USD, a -9.17% move versus the previous session.
What is the market cap of Enlivex Therapeutics (ENLV)?
Enlivex Therapeutics currently has a market capitalization of 205M USD on BioPharmSignal.
What does Enlivex Therapeutics do?
Enlivex Therapeutics is an immunotherapy company focused on macrophage reprogramming and inflammation-related disease. Its story is centered on harnessing innate immunity to address hard-to-treat conditions.
On which exchange is ENLV stock listed?
Enlivex Therapeutics (ENLV) is associated with NASDAQ, Israel and listed in the U, Biopharma.
What is Enlivex?
Enlivex’s catalysts are Allocetra and its osteoarthritis / immunology programs, along with any update that clarifies whether the platform still has a viable path.
Which conditions is Enlivex Therapeutics targeting with Enlivex?
Enlivex Therapeutics is associated with immunology, inflammatory disease based on its company overview and current catalyst commentary.
How does Enlivex Therapeutics describe recent progress with Enlivex?
Enlivex’s catalysts are Allocetra and its osteoarthritis / immunology programs, along with any update that clarifies whether the platform still has a viable path.
What is Therapeutics?
Enlivex Therapeutics is an immunotherapy company focused on macrophage reprogramming and inflammation-related disease.